Corvus Pharmaceuticals (CRVS) Other Non-Current Assets (2015 - 2026)
Corvus Pharmaceuticals (CRVS) posted Other Non-Current Assets of $1.71 million for Q2 2026, up 173.6% from $626,000 a year earlier but down 0.4% from the prior quarter.
Powered by 
Analysis
Corvus Pharmaceuticals (CRVS) Other Non-Current Assets (2015 - 2026) Analysis & Trends
At the end of FY2025, Corvus Pharmaceuticals' Other Non-Current Assets came in at $855,000, up 35.3% from FY2024.
- Annual Other Non-Current Assets shows a five-year compound annual growth rate of 15.6% (FY2020 to FY2025).
- In prior years, Corvus Pharmaceuticals' Other Non-Current Assets was $632,000 in FY2024 (+610.1%), $89,000 in FY2023 (-31.0%), $129,000 in FY2022 (-45.3%) and $236,000 in FY2021 (-43.0%).
- Quarterly Other Non-Current Assets has run from a low of $89,000 in Q3 2023 to a high of $1.72 million in Q1 2026 over five years.
- On a year-over-year basis, Other Non-Current Assets has increased in each of the last eight quarters, with growth averaging 300.7% over the last eight quarters.
- The strongest year-over-year quarter for Other Non-Current Assets in the past five years was Q4 2024, with growth of 610.1%; the weakest was Q1 2022, with a decline of 78.1%.
- According to Business Quant data, Other Non-Current Assets for the three prior quarters was $1.72 million (Q1 2026), $855,000 (Q4 2025) and $852,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,166.82 Bn | 1,135.41 Bn | 19.71 Bn | 7.48 Bn |
| 2 | Johnson & Johnson | 644.52 Bn | 564.38 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 501.88 Bn | 474.99 Bn | 12.70 Bn | 10.73 Bn |
| 4 | Merck | 358.72 Bn | 313.10 Bn | 12.21 Bn | 19.60 Bn |
| 5 | Novartis Ag | 302.27 Bn | 266.26 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 267.62 Bn | 241.31 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.67 Bn | 197.07 Bn | 7.24 Bn | 12.98 Bn |
| 8 | Gilead Sciences | 193.09 Bn | 167.28 Bn | 6.22 Bn | 4.75 Bn |
| 9 | Pfizer | 171.60 Bn | 118.24 Bn | 10.94 Bn | 9.94 Bn |
| 10 | Corvus Pharmaceuticals | 942.15 Mn | 430.59 Mn | - | 1.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.71 Mn |
| Mar 31, 2026 | 1.72 Mn |
| Dec 31, 2025 | 855,000.00 |
| Sep 30, 2025 | 852,000.00 |
| Jun 30, 2025 | 626,000.00 |
| Mar 31, 2025 | 629,000.00 |
| Dec 31, 2024 | 632,000.00 |
| Sep 30, 2024 | 252,000.00 |
| Jun 30, 2024 | 129,000.00 |
| Mar 31, 2024 | 89,000.00 |
| Dec 31, 2023 | 89,000.00 |
| Sep 30, 2023 | 89,000.00 |
| Jun 30, 2023 | 129,000.00 |
| Mar 31, 2023 | 129,000.00 |
| Dec 31, 2022 | 129,000.00 |
| Sep 30, 2022 | 248,000.00 |
| Jun 30, 2022 | 236,000.00 |
| Mar 31, 2022 | 236,000.00 |
| Dec 31, 2021 | 236,000.00 |
| Sep 30, 2021 | 279,000.00 |
API Access
Corvus Pharmaceuticals Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=CRVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "CRVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=CRVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();